# Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients

> **NCT01653106** · NA · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 148 (actual)

## Conditions studied

- Refractory Multiple Myeloma
- Stage I Multiple Myeloma
- Stage II Multiple Myeloma
- Stage III Multiple Myeloma

## Interventions

- **PROCEDURE:** cryotherapy
- **OTHER:** questionnaire administration
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT01653106
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-05
- **Final completion:** 2015-03
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653106, "Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01653106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*